S01GA51 • nafazoline + chlorpheniramine maleate • Sensory organs | Decongestants and antiallergics | Sympathomimetics used as decongestants
The combination of Naphazolinum + Chlorpheniramine Maleate is used for the symptomatic treatment of allergic rhinitis and nasal congestion. It combines the decongestant effect of Naphazolinum with the antihistamine properties of chlorpheniramine, providing rapid symptom relief.
The medication is available as nasal drops and is effective in reducing inflammation, congestion, and nasal itching. It is intended for short-term use, typically no more than 5-7 days.
Side effects may include dryness of the nasal mucosa, drowsiness, or local irritation. Prolonged use may lead to rebound congestion or other complications.
Consult your doctor before use, especially if you have chronic conditions or are taking other medications. Follow the recommended dosage to avoid side effects.
Substance: nafazoline + chlorpheniramine maleate
Date of last drug list: 01-07-2013
Commercial code: W44055001
Concentration: 0.5mg / 0.5mg / ml
Pharmaceutical form: ophthalmic / nose drops solution
Packing volume: 10 ml
Product type: generic
Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.
Manufacturer: FELSIN FARM S.R.L. - ROMANIA
Holder: E.I.P.I.C.O MED S.R.L. - ROMANIA
Number: 11736/2019/01
Shelf life: 3 years-dupa ambalatra pt. comercializare; 28 days-after the first opening of the bottle